These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 206626)

  • 1. In vitro comparison of foot-and-mouth disease virus subtype variants causing disease in vaccinated cattle.
    Anderson EC; Doughty WJ; Anderson J; Baber D
    J Hyg (Lond); 1978 Jun; 80(3):451-9. PubMed ID: 206626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of an outbreak of foot-and-mouth disease in vaccinated dairy cattle in Thailand.
    Gleeson LJ; Chamnanpood P; Cheunprasert S; Srimasartitkol N; Trisasarom A
    Aust Vet J; 1995 Jan; 72(1):21-4. PubMed ID: 8787521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of specific VIA antibodies in foot-and-mouth disease].
    Tekerlekov P; Nikolova E; Veleva E; Ivanov Ia
    Vet Med Nauki; 1987; 24(9):3-8. PubMed ID: 2451341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of repeated vaccination in an enzootic foot-and-mouth disease area on the incidence of virus carrier cattle.
    Anderson EC; Doughty WJ; Anderson J
    J Hyg (Lond); 1974 Oct; 73(2):229-35. PubMed ID: 4370898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Humoral immune response in cattle vaccinated against aphthovirus. Study of the kinetics of protective and neutralizing antibodies].
    Rojas GB; Rottenberg ME; Brunengo AM
    Rev Argent Microbiol; 1984; 16(4):195-208. PubMed ID: 6101040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
    Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations.
    Terpstra C; Van Maanen C; Van Bekkum JG
    Res Vet Sci; 1990 Sep; 49(2):236-42. PubMed ID: 2173088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
    Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.
    Hunter P
    Rev Sci Tech; 1996 Sep; 15(3):913-22. PubMed ID: 9025141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.
    Alonso A; Darsie GC; Teixeira AC; Reis JL; Mesquita JA
    Vaccine; 1994 Jun; 12(8):682-6. PubMed ID: 8091844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus.
    Kitching RP; Rendle R; Ferris NP
    Vaccine; 1988 Oct; 6(5):403-8. PubMed ID: 2848376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the thermal stability of isolates of foot-and-mouth disease type SAT 2 and its significance in the selection of vaccine strains.
    Anderson EC; Doughty WJ; Spooner PR
    J Comp Pathol; 1982 Oct; 92(4):495-507. PubMed ID: 6296205
    [No Abstract]   [Full Text] [Related]  

  • 18. The foot-and-mouth disease virus subtype variants in Kenya.
    Anderson EC; Anderson J; Doughty WJ
    J Hyg (Lond); 1974 Oct; 73(2):237-44. PubMed ID: 4371008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.
    Graves JH; McKercher PD; Callis JJ
    Am J Vet Res; 1972 Apr; 33(4):765-8. PubMed ID: 4336082
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.